BMRA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Biomerica Inc (BMRA) is not a good buy at this time for a beginner investor with a long-term strategy. The stock shows bearish technical indicators, weak financial performance, and lacks positive catalysts or trading signals. It is better to hold off on investing until there are clear signs of improvement in the company's fundamentals or market sentiment.
The stock is in a bearish trend with MACD negatively expanding, RSI at 22.908 indicating oversold conditions, and moving averages showing a bearish alignment (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level (S1: 1.926), but there is no indication of a reversal.
NULL identified. There is no recent news or significant insider/hedge fund activity.
The stock price has declined in both pre-market (-1.97%) and regular market (-2.96%). Financial performance is weak, with revenue dropping by -26.04% YoY and gross margin plummeting by -84.24% YoY. The stock also has a 40% chance to decline further in the next day, week, and month based on similar candlestick patterns.
In Q2 2026, revenue dropped to $1,210,000 (-26.04% YoY), net income improved to -$1,320,000 (+38.95% YoY), and EPS slightly increased to -0.45 (+2.27% YoY). However, gross margin dropped significantly to 4.21 (-84.24% YoY), indicating poor cost management.
No analyst ratings or price target changes available for this stock.
